Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Inferiority, Randomized, Blind Laboratory Analysis, Controlled Trial Comparing One and Two Doses Regimes of Oxfendazole Versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis

NCT06367361 is registered in ClinicalTrials.gov with Universidad Peruana Cayetano Heredia as lead sponsor.

NCT NCT06367361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Inferiority, Randomized, Blind Laboratory Analysis, Controlled Trial Comparing One and Two Doses Regimes of Oxfendazole Versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis
Lead sponsor
Universidad Peruana Cayetano Heredia
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
April 15, 2029
Enrollment
336 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fascioliasis